HomePBYI • NASDAQ
Puma Biotechnology Inc
$4.66
Pre-market:
$3.65
(21.67%)-1.01
Closed: Mar 19, 4:05:14 AM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$5.00
Day range
$4.48 - $5.00
Year range
$2.13 - $7.73
Market cap
224.65M USD
Avg Volume
737.23K
P/E ratio
10.26
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
72.18M9.90%
Operating expense
32.43M-20.55%
Net income
12.27M318.84%
Net profit margin
17.00299.06%
Earnings per share
0.31542.86%
EBITDA
18.31M74.92%
Effective tax rate
4.19%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
95.94M18.34%
Total assets
230.53M3.81%
Total liabilities
177.09M-11.66%
Total equity
53.44M
Shares outstanding
48.21M
Price to book
4.46
Return on assets
17.76%
Return on capital
24.41%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
12.27M318.84%
Cash from operations
10.46M36.08%
Cash from investing
-8.17M31.19%
Cash from financing
Net change in cash
2.28M229.90%
Free cash flow
13.41M40.12%
About
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
Founded
2007
Employees
185
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu